You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SCIG

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myasthenia Gravis Trial in Toronto (subcutaneous immunoglobulin (SCIG), intravenous immunoglobulin + subcutaneous immunoglobulin

Recruiting
  • Myasthenia Gravis
  • subcutaneous immunoglobulin (SCIG)
  • intravenous immunoglobulin + subcutaneous immunoglobulin (SCIG)
  • Toronto, Ontario, Canada
    University Health Network
Nov 21, 2022

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • No Intervention
  • (no location specified)
Nov 21, 2023

CIDP, Immunoglobulin Deficiency, Chronic Inflammatory Demyelinating Polyneuropathy Trial in New Brunswick (Intravenous immune

Recruiting
  • CIDP
  • +2 more
  • Intravenous immune globulin G
  • Subcutaneous immune globulin G
  • New Brunswick, New Jersey
    Rutgers, The State University of New Jersey Clinical Research Ce
Oct 13, 2022

Myasthenia Gravis Trial in Edmonton, Vancouver (Human normal immunoglobulin G (IgG))

Recruiting
  • Myasthenia Gravis
  • Human normal immunoglobulin G (IgG)
  • Edmonton, Alberta, Canada
  • +1 more
May 25, 2022

Myasthenia Gravis Trial in Canada, United States (HIZENTRA ®)

Completed
Has Results
  • Myasthenia Gravis
  • HIZENTRA ®
  • Phoenix, Arizona
  • +4 more
May 9, 2021

Conducted in Poland to Document Management and Clinical Outcome

Completed
  • Primary Immunodeficiencies (PID)
    • Gdańsk, Poland
    • +4 more
    Nov 15, 2021

    Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic

    Not yet recruiting
    • Haematological Malignancy
    • Hypogammaglobulinemia
    • trimethoprim-sulfamethoxazole (co-trimoxazole)
    • +2 more
    • (no location specified)
    Jan 4, 2023

    Action of SCIg in Patients With Stiff Person Syndrome (SPS)

    Unknown status
    • Stiff-Person Syndrome
    • HyQvia
    • (no location specified)
    May 13, 2019

    Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety

    Recruiting
    • Primary Immunodeficiency Diseases (PID)
    • Moscow, Russian Federation
      Dmitry Rogachev National Research Center of Pediatric Hematology
    Aug 8, 2023

    Primary Immunodeficiency Trial in France (IgHy10)

    Completed
    • Primary Immunodeficiency
    • Lille, France
    • +6 more
    Jun 24, 2019

    Subcutaneous Immunoglobulin in Primary and Secondary

    Not yet recruiting
    • Primary Immune Deficiency Disorder
    • Secondary Immune Deficiency
    • Edmonton, Alberta, Canada
      University of Alberta
    Jun 14, 2022

    Hypogammaglobulinemia Trial in Toronto (subcutaneous immunoglobulin)

    Completed
    • Hypogammaglobulinemia
    • subcutaneous immunoglobulin
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    May 7, 2019

    Hizentra® in Inflammatory Neuropathies - pHeNIx Study

    Suspended
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Hizentra
    • Angers, France
    • +16 more
    Mar 4, 2022

    Chronic Inflammatory Demyelinating Polyneuropathy Trial in Tampa (Immune Globulin Subcutaneous (Human))

    Completed
    • Chronic Inflammatory Demyelinating Polyneuropathy
    • Immune Globulin Subcutaneous (Human)
    • Tampa, Florida
      USF Dept of Neurology
    Sep 14, 2021

    CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Trial in Denmark (Immunoglobulin)

    Recruiting
    • CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
    • Immunoglobulin
    • Aalborg, Denmark
    • +3 more
    Oct 9, 2020

    Primary Immune Deficiency Trial in Worldwide (Newnorm)

    Recruiting
    • Primary Immune Deficiency
    • Newnorm
    • Irvine, California
    • +16 more
    Jul 1, 2022

    Primary Immunodeficiency Trial in United States (IGSC 20%)

    Completed
    • Primary Immunodeficiency
    • IGSC 20%
    • Birmingham, Alabama
    • +11 more
    Nov 2, 2022

    Real-world Usage of HyQvia in Multiple Myeloma Secondary

    Not yet recruiting
    • Multiple Myeloma
    • Secondary Immunodeficiency (SID)
    • No Intervention
    • (no location specified)
    May 19, 2023

    Real-world CANadian CUvitru Non-Interventional Study in Subjects

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • CUVITRU
    • Hamilton, Ontario, Canada
    • +2 more
    Mar 3, 2021

    Patients With Myasthenic Syndrome and COVID-19 Infection

    Recruiting
    • Myasthenia Gravis
      • Angers, France
      • +9 more
      Dec 31, 2020

      Database for Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

      Terminated
      • Primary Immune Deficiency Disorder
      • Immunoglobulin Therapy
      • Lenexa, Kansas
        BriovaRx Infusion Services
      Aug 5, 2019

      CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))

      Completed
      • CVI - Common Variable Immunodeficiency
      • C1-esterase inhibitor [recombinant] (C1-INH-R)
      • Centennial, Colorado
        IMMUNOe Research Centers
      Feb 11, 2021

      Primary Immune Deficiency Diseases (PIDD) Trial in Canada, United States (10% IGIV)

      Unknown status
      • Primary Immune Deficiency Diseases (PIDD)
      • 10% IGIV
      • Los Angeles, California
      • +11 more
      May 6, 2020

      Primary Immunodeficiency Trial in Worldwide (IGSC 20%)

      Completed
      Has Results
      • Primary Immunodeficiency
      • IGSC 20%
      • Auchenflower, Australia
      • +22 more
      Jun 12, 2020

      Tolerability and Efficacy of IVIG

      Completed
      Has Results
      • Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
      • Octagam IVIG 5% or 10%
      • Panzyga
      • Gmunden, Austria
      • +37 more
      Jun 5, 2021